News Releases

News & Events

News Releases

Synteract Experts Speaking at Outsourcing in Clinical Trials U.S. and European Shows

Global contract research organization expands reach with Outsourcing in Clinical Trials East Coast and Outsourcing in Clinical Trials Europe conferences in May

SAN DIEGO – May 6, 2014 – Synteract, a full-service, global contract research organization (CRO), will attend and present at two industry conferences in May: Outsourcing in Clinical Trials (OCT) East Coast and Outsourcing in Clinical Trials Europe. Members of Synteract’s project management leadership team will present at the conferences that serve as a forum for in-depth discussion about current issues within vendor selection, clinical trial agreements and service-provider management.

Outsourcing in Clinical Trials East Coast takes place in Philadelphia, Pennsylvania, on May 13-14. The 2014 event is focused on how companies from the region can implement effective clinical outsourcing strategies. Synteract will exhibit at booth #14. Project Director Cheryl Johnson will present “Achieving a Key Milestone: Site Activation” at 2:15 p.m. on Tuesday, May 13. Attendees will learn how to establish the Study Start-Up team, identify critical steps for activating a site, implement effective tracking, proactive management and site communication, and more. To set an appointment in advance, contact Business Development Director Megan O’Keefe at 917-692-8047 or

Synteract will exhibit at booth #21 during Outsourcing in Clinical Trials Europe in Brussels, Belgium, on May 21-22. The conference brings together senior industry representatives to discuss the latest challenges within clinical outsourcing such as vendor sourcing, selection and contracting, as well as communication, oversight and management. Synteract Italia Director of Project Management Massimo Ildebrando will present “Planning for Global Clinical Trials: Benefits, Challenges and Solutions” at 2:45 p.m. on Wednesday, May 21. The presentation will cover selecting countries based on assessment of disease incidence, understanding the role of feasibility studies, addressing language challenges and cultural differences, managing variations among regulatory bodies in rules and requirements, and more. To make an appointment in advance, contact Business Development Director Alexandre Wallard at +32 (0)2464 39 03 or

Synteract will also exhibit at DIA 2014 in San Diego, California, this summer. The company’s Intelligent Clinical Development (ICD+) platform leverages the organization’s deep clinical development expertise, appropriate technology and optimized execution to drive solution-oriented efficiencies on a global scale. The elements of this comprehensive methodology identify ways to save time and cost during the drug development process.

About Synteract 
Synteract is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and in more than 50 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, Synteract provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster. 

Beth Walsh


Contact Synteract

Tell us how to stay in touch with you: